✦ LIBER ✦

Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: A southwest oncology group study

✍ Scribed by Dr. Carolyn L. Bigelow; Kenneth Kopecky; Joe C. Files; David Head; David A. Lipschitz; Michael Grever; Frederick R. Appelbaum

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 438 KB
Volume: 48
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830480404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

13-cis-retinoic acid in the treatment of

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group

✍ Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e

Fractionated doses of gemtuzumab ozogami

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association

✍ Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views